Bausch Health Files Proxy Materials
Ticker: BHC · Form: DEFA14A · Filed: Apr 22, 2025 · CIK: 885590
Sentiment: neutral
Topics: proxy-statement, shareholder-materials, corporate-governance
TL;DR
Bausch Health dropped more proxy docs, shareholders need to pay attention.
AI Summary
Bausch Health Companies Inc. filed a Definitive Additional Materials proxy statement on April 22, 2025. This filing relates to the company's proxy materials, which were previously filed. The company, formerly known as Valeant Pharmaceuticals International, Inc., is headquartered in Laval, Quebec.
Why It Matters
This filing indicates that Bausch Health is providing additional information to shareholders related to upcoming proxy votes, which is crucial for shareholder engagement and corporate governance.
Risk Assessment
Risk Level: low — This is a routine filing of additional proxy materials, not indicating any new or unusual risks.
Key Players & Entities
- Bausch Health Companies Inc. (company) — Registrant
- Valeant Pharmaceuticals International, Inc. (company) — Former company name
- 20250422 (date) — Filing date
FAQ
What type of filing is this DEFA14A?
This is a Definitive Additional Materials filing.
Who is the filing company?
The filing company is Bausch Health Companies Inc.
When was this filing made?
The filing was made on April 22, 2025.
What was Bausch Health Companies Inc. formerly known as?
Bausch Health Companies Inc. was formerly known as Valeant Pharmaceuticals International, Inc.
Where is Bausch Health Companies Inc. located?
Bausch Health Companies Inc. is located at 2150 St. Elzear Blvd. West, Laval, Quebec, H7L 4A8.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 22, 2025 regarding Bausch Health Companies Inc. (BHC).